This one-hour, journal article-based activity examines ongoing clinical trials for cocaine use disorder (CUD) and evaluates how well ongoing studies align with recent Food and Drug Administration (FDA) recommendations. Learners will explore trends in trial design, including the use of pharmacologic, behavioral, device-based, and digital interventions, while examining common strengths and gaps in current research. The activity also discusses how adherence to regulatory guidance may influence the development, evaluation, and future implementation of effective treatments for CUD.

This one-hour, journal article-based activity examines differences in medication for opioid use disorder (MOUD) implementation between primary care clinics and specialty addiction treatment programs. Learners will explore how organizational capacity, workforce characteristics, implementation climate, and community-level factors influence the adoption and delivery of MOUD across treatment settings. The article also examines opportunities to tailor implementation strategies to address setting-specific barriers, improve access to evidence-based treatment, and support equitable expansion of MOUD services for individuals with opioid use disorder.

This 45-minute, on-demand session from the ASAM 2026 Review Course provides an overview of complex ethical and legal issues when treating substance use disorder and other co-occurring disorders as well as issues surrounding criminal justice, impaired professionals, minors, and pregnant patients.

This 30-minute, on-demand session from the ASAM 2026 Review Course reviews epidemiology, screening, complications of use, and unique treatment issues for adolescents, young adults, and the elderly.

This 55-minute, on-demand session from the ASAM 2026 Review Course focuses on the interactions between disorders, differential diagnoses, and management as well as a framework to assess patients for psychiatric co-morbidities.